Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
In Candida albicans , the ERG11 gene encodes lanosterol demethylase, the target of the azole antifungals. Mutations in ERG11 that result in an amino acid substitution alter the abilities of the azoles to bind to and inhibit Erg11, resulting in resistance. Although ERG11 mutations have been observed in clinical isolates, the specific contributions of individual ERG11 mutations to azole resistance in C. albicans have not been widely explored. We sequenced ERG11 in 63 fluconazole (FLC)-resistant clinical isolates. Fifty-five isolates carried at least one mutation in ERG11 , and we observed 26 distinct positions in which amino acid substitutions occurred. We mapped the 26 distinct variant positions in these alleles to four regions in the predicted structure for Erg11, including its predicted catalytic site, extended fungus-specific external loop, proximal surface, and proximal surface-to-heme region. In total, 31 distinct ERG11 alleles were recovered, with 10 ERG11 alleles containing a single amino acid substitution. We then characterized 19 distinct ERG11 alleles by introducing them into the wild-type azole-susceptible C. albicans SC5314 strain and testing them for susceptibilities to FLC, itraconazole (ITC), and voriconazole (VRC). The strains that were homozygous for the single amino acid substitutions Y132F, K143R, F145L, S405F, D446E, G448E, F449V, G450E, and G464S had a ≥4-fold increase in FLC MIC. The strains that were homozygous for several double amino acid substitutions had decreased azole susceptibilities beyond those conferred by any single amino acid substitution. These findings indicate that mutations in ERG11 are prevalent among azole-resistant clinical isolates and that most mutations result in appreciable changes in FLC and VRC susceptibilities.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Finally, in Candida auris, ERG11 polymorphisms as well as an increased number of ERG11 gene copies are thought to be responsible for its largely intrinsic azole resistance37–40”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [38]
In the citing paper
“Aneuploidy can alter fluconazole tolerance in C. albicans drug38,51.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [38]
In the citing paper
“Aneuploidy and/or loss of heteroresistance are rapidly acquired genome changes that can result in increased tolerance. and are likely to affect one or several genes that alter tolerance level.”
From Drug resistance and tolerance in fungi. (2020) · cites this paper as [38]
In the citing paper
“Frequently reported in association with triazole resistance in both yeast and molds, mutations in sterol-demethylase have been observed to have variable and agent specific effects on the MICs of triazole antifungals, potentially as a result of agent-specific stabilizing interactions with sterol-demethylase residues (4, 5).”
From Delineation of the Direct Contribution of Candida auris ERG11 Mutations to Clinical Triazole Resistance (2021) · cites this paper as [5]
In the citing paper
“In both Candida albicans and Aspergillus fumigatus, the mutation encoding a tyrosine to phenylalanine amino acid substitution at a specific residue localized to the sterol-demethylase catalytic domain (Y132F in C. albicans CaERG11 and Y121F in A. fumigatus Afcyp51A) confers increased resistance to all triazoles except for posaconazole (4–7).”
From Delineation of the Direct Contribution of Candida auris ERG11 Mutations to Clinical Triazole Resistance (2021) · cites this paper as [5]
10 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
All-Atom Empirical Potential for Molecular Modeling and Dynamics Studies of Proteins
MacKerell, A. D., Bashford, D., Bellott, M., Dunbrack, R. L., Evanseck, J. D., Field, M. J., Fischer, S., Gao, J., Guo, H., Ha, S., et al. (1998) · The Journal of Physical Chemistry B · doi:10.1021/jp973084f · Cited by 14,311
Amino acid substitution matrices from protein blocks.
Henikoff, S., & Henikoff, J. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.22.10915 · Cited by 6,218
Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94
Halgren, T. A. (1996) · Journal of Computational Chemistry · doi:10.1002/(sici)1096-987x(199604)17:5/6<490::aid-jcc1>3.0.co;2-p · Cited by 5,306
Clinical and Laboratory Standards Institute
(2019) · Springer Reference Medizin · doi:10.1007/978-3-662-48986-4_300416 · Cited by 5,091
The SAT1 flipper, an optimized tool for gene disruption in Candida albicans
Reuß, O., Vik, Å., Kolter, R., & Morschhäuser, J. (2004) · Gene · doi:10.1016/j.gene.2004.06.021 · Cited by 742
Aneuploidy and Isochromosome Formation in Drug-Resistant Candida albicans
Selmecki, A., Forche, A., & Berman, J. (2006) · Science · doi:10.1126/science.1128242 · Cited by 733
Cytochrome P450 and the Individuality of Species
Nelson, D. R. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1352 · Cited by 591
Perea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470
Sanglard, D., Ischer, F., Koymans, L., & Bille, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465
Resistance Mechanisms in Clinical Isolates of Candida albicans
White, T. C., Holleman, S., Dy, F., Mirels, L. F., & Stevens, D. A. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1704-1713.2002 · Cited by 461
Research works printed but not linked: 1
- Sanglard D, Bille J. 2002. Action of and resistance to antifungal agents, p 370. In Calderone RA (ed), Candida and candidiasis. American Society for Microbiology, Washington, DC.
Cited by
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A. L., Calvo, B., Cuomo, C. A., Desjardins, C. A., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/ciw691 · Cited by 1,662
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
Whaley, S. G., Berkow, E. L., Rybak, J. M., Nishimoto, A. T., Barker, K. S., & Rogers, P. D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02173 · Cited by 900
“Recently, 63 fluconazole-resistant C. albicans clinical isolates were examined for mutations within their ERG11 alleles, and 55 were found to carry at least one mutation that resulted in amino acid substitutions, with nine such predicted amino acid substitutions being novel (Flowers et al., 2015).”
BackgroundSelf-citationAntifungal Drug Resistance: Molecular Mechanisms in Candida albicans and Beyond
Lee, Y., Puumala, E., Robbins, N., & Cowen, L. E. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c00199 · Cited by 801
Drug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642
Chowdhary, A., Prakash, A., Sharma, C., Kordalewska, M., Kumar, A., Sarma, S., Tarai, B., Singh, A., Upadhyaya, G., Upadhyay, S., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx480 · Cited by 577
Metadata
- Authors
- Flowers, S. A., Colón, B., Whaley, S. G., Schuler, M. A., & Rogers, P. D.
- Affiliations
- University of Tennessee Health Science Center (US)
- University of Illinois Urbana-Champaign (US)
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2015-01
- Volume
- 59
- Issue
- 1
- Pages
- 450-460
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- PMC
- PMC4291385
- OpenAlex
- W2151649073
- Cited by
- 294
- References
- 46
- Citations by year
- 2026: 25 · 2025: 33 · 2024: 31 · 2023: 39 · 2022: 31 · 2021: 29 · 2020: 33 · 2019: 26 · 2018: 15 · 2017: 17 · 2016: 8 · 2015: 7
- FWCI
- 7.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- journals.asm.org/non-commercial-tdm-license (tdm)
- Locations
- Antimicrobial Agents and Chemotherapy (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Allergy and Infectious Diseases (R01AI058145)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Fungal Plant Pathogen Control
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Keywords
- Candida albicans, ERG11, azole resistance, fluconazole resistance, itraconazole, voriconazole, amino acid substitutions, clinical isolates, double mutations, antifungal susceptibility, drug target mutations
- MeSH terms
- Antifungal Agents, Azoles, Candida albicans, Candidiasis, Humans, Microbial Sensitivity Tests, Molecular Sequence Data, Fluconazole, Itraconazole, Amino Acid Substitution, Catalytic Domain, Drug Resistance, Fungal, Sterol 14-Demethylase, 14-alpha Demethylase Inhibitors, Voriconazole
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans. https://app.cochat.ai/papers/10.1128/aac.03470-14
- The paper
- Flowers, S. A., Colón, B., Whaley, S. G., Schuler, M. A., & Rogers, P. D. (2015). Contribution of Clinically Derived Mutations in ERG11 to Azole Resistance in Candida albicans. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.03470-14
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.